Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 161

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1B
Chunk 161
---
 has a relationship to us that is material to that member’s ability to be independent
from management in connection with carrying out such member’s duties as a compensation committee member.

The
compensation committee’s main purpose is to review and recommend policies relating to compensation and benefits of our officers
and employees. Our compensation committee is responsible for, among other things:

    ●
    reviewing,
    approving, and determining, or making recommendations to our board of directors regarding, the compensation and compensation arrangements
    of our executive officers;

    ●
    administering
    our equity compensation plans;

69

    ●
    reviewing
    and approving, or making recommendations to our board of directors regarding, incentive compensation and equity compensation plans;
    and

    ●
    establishing
    and reviewing general policies relating to compensation and benefits of our employees.

Our
compensation committee operates under a written charter that satisfies the applicable rules and regulations of the SEC and the listing
standards of Nasdaq, a copy of which is available on our website.

Nominating
and Corporate Governance Committee

Our
nominating and corporate governance committee consists of Dr. Matthew Del Giudice and Dr. Denil Shekhat with Dr. Matthew Del Giudice
serving as the chair of the nominating and corporate governance committee. Each member of the committee meets the requirements for independence
under the listing standards of Nasdaq and SEC rules and regulations.

Our
nominating and corporate governance committee is responsible for, among other things:

    ●
    identifying,
    evaluating, and selecting, or making recommendations to our board of directors regarding, nominees for election to our board of directors
    and its committees;

    ●
    developing
    and overseeing the annual evaluation of our board of directors and of its committees;

    ●
    considering
    and making recommendations to our board of directors regarding the composition of our board of directors and its committees;

    ●
    overseeing
    our corporate governance practices; and

    ●
    making
    recommendations to our board of directors regarding corporate governance guidelines.

Our
nominating and corporate governance committee operates under a written charter that satisfies the applicable listing standards of Nasdaq,
a copy of which is available on our website.

Compensation
Committee Interlocks and Insider Participation

None
of the members of our compensation committee is a current or former executive officer or employee of our company. None of our executive
officers serves as a member of the compensation committee of any entity that has